证券记录 · 已归档季度
IDYA
IDEAYA Biosciences, Inc. · Healthcare · Biotechnology
16被追踪持有人
0Δ持有人
43.75M持有股份
$919.60M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +5.5% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 101 | +5 | 68.11M | $2.53B | +11 | −5 |
| Q1 2026 | 98 | +2 | 72.39M | $2.41B | +9 | −8 |
| Q4 2025 | 96 | 0 | 74.31M | $2.57B | +1 | n/a |
| Q3 2025 | 17 | -1 | 45.06M | $1.23B | n/a | −2 |
| Q2 2025 | 16 | 0 | 43.75M | $919.60M | +1 | −1 |
| Q1 2025 | 13 | -1 | 14.55M | $238.33M | +1 | −2 |
| Q4 2024 | 14 | +1 | 14.99M | $385.22M | +1 | n/a |
| Q3 2024 | 12 | -1 | 10.73M | $339.97M | n/a | −1 |
| Q2 2024 | 13 | n/a | 11.98M | $420.72M | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 13.14M | n/a | $276.15M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 2 | BlackRock ✦ (被动) | 8.84M | n/a | $185.87M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 3 | Point72 Asset Management ✦ | 5.03M | +3488.4% | $105.69M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (被动) | 4.94M | n/a | $103.88M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 5 | State Street Global Advisors ✦ (被动) | 3.39M | -1.8% | $71.17M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.11M | +1.6% | $44.42M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 1.90M | -45.2% | $40.04M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 1.83M | +21.3% | $38.38M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 9 | Adage Capital Partners ✦ | 1.24M | +4.2% | $26.02M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 922.09K | -4.5% | $19.38M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 156.64K | -66.6% | $3.29M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 98.15K | -68.2% | $2.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | Millennium Management ✦ | 66.69K | -87.8% | $1.40M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Wellington Management ✦ | 35.84K | -1.8% | $753,252 | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 15 | Norges Bank ✦ (被动) | 30.59K | 0.0% | $642,981 | 0.0% | Held | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 20.36K | 新增 | $427,947 | 0.0% | New | 1 | SEC ↗ ×5 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| AQR Capital Management | $427,947 | 0.0% |
已清仓
| Renaissance Technologies | $5.86M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 253 持有人, 94.40M 股份, $3.10B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 06
Hata Yujiro S
Officer, Director · 25.54K 股 · $954,787
Oct 06
Hata Yujiro S
Officer, Director · 800 股 · $30,610
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G: BAKER BROS. ADVISORS LP
Jul 31
SC 13G: VANGUARD CAPITAL MANAGEMENT LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据